Sara
Villar Fernández
Colaboradora Clínica
Universidade da Coruña
La Coruña, España
Publicaciones en colaboración con investigadores/as de Universidade da Coruña (4)
2025
-
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
Blood Cancer Journal, Vol. 15, Núm. 1
-
Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC
Frontiers in Immunology, Vol. 16
2024
-
Cardiac events after allo-HCT in patients with acute myeloid leukemia
Blood Advances, Vol. 8, Núm. 21, pp. 5497-5509
-
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC
Bone Marrow Transplantation, Vol. 59, Núm. 12, pp. 1694-1703